(Hedgeweek) In recent months, Market Neutral L/S strategies underperformed other hedge fund strategies, in a context where risk assets rallied following the Pfizer vaccine announcement in November 2020.
Market neutral long-short to remain under pressure, says Lyxor Research
This entry was posted in Syndicated. Bookmark the permalink.
